Reuters
Shares of several makers of the drugs, including British rivals GlaxoSmithKline Plc and AstraZeneca Plc, fell sharply after the testimony.
Dr. David Graham, speaking at a Senate hearing, singled out Abbott Laboratories Inc.'s weight-loss drug Meridia, AstraZeneca's cholesterol fighter Crestor, Pfizer Inc.'s arthritis treatment Bextra, Roche's acne drug Accutane and GlaxoSmithKline's asthma drug Serevent.
More... |